Cutaneous Crohn's disease treated with infliximab and 4 years of follow up
- PMID: 23772972
- DOI: 10.1111/ajd.12069
Cutaneous Crohn's disease treated with infliximab and 4 years of follow up
Abstract
Metastatic Crohn's disease (MCD) is a rare, non-contiguous cutaneous manifestation of Crohn's disease. To date, there have been only four reports in the literature of an effective treatment of this condition with infliximab and there are no long-term follow-up studies on adult MCD patients treated with infliximab. We present a case of MCD treated with infliximab with 4.5 years of follow up.
Keywords: infliximab; metastatic Crohn's disease.
© 2013 The Australasian College of Dermatologists.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
